Month: June 2024

Brooklyn, N.Y.-based architect Adare Brown has been selected as winner of the 2023-24 James Harrison Steedman Memorial Fellowship in Architecture. Established in 1926, the biannual $75,000 prize, which supports research through international travel, is among the largest such fellowships in the United States.

As psychedelic-assisted therapy gains mainstream acceptance, the role of social workers, who provide a significant portion of mental health services in the United States, will become increasingly important in this emerging field, says an expert on mental health in the Brown School.

Researchers at Washington University School of Medicine in St. Louis have found that safety interventions — such as walkers, grab bars, ramps and other home modifications — allow many stroke survivors to keep living independently in their homes and may reduce their risk of death.

Kara Andres, a postdoctoral fellow with the Living Earth Collaborative, collected samples from Simpson Lake in Valley Park, Mo., one of about 800 lakes worldwide that were surveyed on the UN’s International Day of Biodiversity.

In her new book, political scientist Taylor Carlson, in Arts & Sciences, explores how political information changes as it flows from the news media to person to person. Her research shows that socially transmitted information becomes sparse, biased, less accurate and mobilizing — fueling a “distorted democracy.”

Images from on and around the Washington University campuses.

Researchers at Washington University have developed a noninvasive technology combining a holographic acoustic device with genetic engineering that allows them to precisely target affected neurons in the brain.

Hani Zaher, a professor of biology in Arts & Sciences, published a study in Molecular Cell that dives into the mechanisms behind the ways cells respond to stress.

Arpita Bose, an associate professor of biology in Arts & Sciences, will travel to Belgium next year to continue her work on the green potential of purple bacteria.

In a new study, a team of researchers at Washington University School of Medicine in St. Louis reports that a drug approved by the FDA for another condition may stabilize vision for patients with RVCL-S, a rare genetic disease.